Xue Wang

发表

Correlation of Cytokine Release Syndrome With Prognosis After Chimeric Antigen Receptor T Cell Therapy: Analysis of 54 Patients With Relapsed or Refractory Multiple Myeloma

Kailin Xu, L. Zeng, Jiang Cao, 2022, Frontiers in Immunology.

Downregulation of long non-coding RNA TUG1 suppresses tumor growth by promoting ubiquitination of MET in diffuse large B-cell lymphoma

K. Qi, Kailin Xu, Jiang Cao, 2019, Molecular and Cellular Biochemistry.

The efficacy and safety of cyclosporine A plus androgen versus androgen alone for adult patients with non-severe aplastic anemia in China: a meta-analysis of randomized controlled trials

Jing-jing Zhu, Kailin Xu, Jiang Cao, 2022, Hematology.

Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia

A. Larochelle, Kailin Xu, Jiang Cao, 2019, Annals of Hematology.

Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection

R. Gale, Junnian Zheng, Xi Zhang, 2020, Leukemia.

Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma.

Junnian Zheng, K. Qi, Kailin Xu, 2021, Transplantation and cellular therapy.

Cdc42 inhibitor ML141 enhances G-CSF-induced hematopoietic stem and progenitor cell mobilization

K. Zhao, J. Qiao, Kailin Xu, 2014, International Journal of Hematology.

Humanized CD19‐targeted chimeric antigen receptor T (CAR‐T) cells for relapsed/refractory pediatric acute lymphoblastic leukemia

Junnian Zheng, Gang Wang, K. Qi, 2021, American journal of hematology.

Downregulation of long non-coding RNA TUG1 suppresses tumor growth by promoting ubiquitination of MET in diffuse large B-cell lymphoma

K. Qi, Kailin Xu, Jiang Cao, 2019, Molecular and Cellular Biochemistry.

Impact of glucocorticoids on short-term and long-term outcomes in patients with relapsed/refractory multiple myeloma treated with CAR-T therapy

W. Chen, Yuekun Qi, K. Qi, 2022, Frontiers in Immunology.

An Analysis of Cardiac Disorders Associated With Chimeric Antigen Receptor T Cell Therapy in 126 Patients: A Single-Centre Retrospective Study

Junnian Zheng, K. Qi, J. Qiao, 2021, Frontiers in Oncology.

Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma.

Yuekun Qi, K. Qi, Kailin Xu, 2023, Cytotherapy.

Anti–G Protein–Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial

Yuekun Qi, R. Yao, K. Qi, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment outcome of 301 aplastic anemia patients in China: a 10-year follow-up and real-world data from single institute experience

K. Qi, Kailin Xu, Zhen-Yu Li, 2021, Hematology.

Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy.

K. Qi, J. Qiao, Hai Cheng, 2024, Cytotherapy.

Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapy.

K. Qi, J. Qiao, Hai Cheng, 2023, Clinical and experimental medicine.